http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102862985-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02
filingDate 2012-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102862985-B
titleOfInvention A kind of preparation of hydrolyzable phosphorus potassium silicate calcium active material and application thereof
abstract The invention discloses a kind of preparation and application thereof of hydrolyzable phosphorus potassium silicate calcium active material, with silica quartz powder, potassium primary phosphate, calcium oxide for main raw material, salt of wormwood makees auxiliary agent by mass percentage: silicon-dioxide 44 ± 6%, potassium primary phosphate 17 ± 3%, salt of wormwood 10 ± 3%, calcium oxide 28 ± 4% is put into high-temperature smelting pot after mixing and is heated to 1450-1550 DEG C and carries out high-temperature liquid-phase chemical reactive synthesis phosphorus potassium silicate calcium; Synthesis phosphorus potassium silicate calcium is cooled to normal temperature; Re-use the granular size that phosphorus potassium silicate calcium is crushed to 1 ~ 500 μm by airflow milling; The present invention aims to provide a kind of for controlling hemodia, the preparation suppressing plaque, firm adamantine hydrolyzable phosphorus potassium silicate calcium active material and application thereof.
priorityDate 2012-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449122806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86752264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71295848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451219335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451816491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447551873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451024787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559532

Total number of triples: 50.